Toxicity of pelvic nodal radiation for localized prostate cancer.
作者信息
Haque Waqar, Butler E Brian, Teh Bin S
机构信息
Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, USA.
出版信息
Ann Transl Med. 2019 Dec;7(Suppl 8):S359. doi: 10.21037/atm.2019.09.57.
Abstract
摘要
相似文献
1
Toxicity of pelvic nodal radiation for localized prostate cancer.
Ann Transl Med. 2019 Dec;7(Suppl 8):S359. doi: 10.21037/atm.2019.09.57.
2
Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy.
Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1262-9. doi: 10.1016/j.ijrobp.2005.07.952.
3
Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial.
Acta Oncol. 2018 Mar;57(3):368-374. doi: 10.1080/0284186X.2017.1388539. Epub 2017 Oct 14.
4
Nodal Clearance Rate and Long-Term Efficacy of Individualized Sentinel Node-Based Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):263-71. doi: 10.1016/j.ijrobp.2015.10.031. Epub 2015 Dec 10.
5
Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial.
Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):85-92. doi: 10.1016/j.ijrobp.2015.09.020. Epub 2015 Sep 25.
6
Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review.
Eur Urol. 2019 Mar;75(3):464-476. doi: 10.1016/j.eururo.2018.12.003. Epub 2018 Dec 17.
7
Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer.
Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):29-35. doi: 10.1016/j.ijrobp.2008.10.086. Epub 2009 May 19.
8
A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes.
Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):898-902. doi: 10.1016/j.ijrobp.2007.02.030. Epub 2007 Apr 24.
9
[Therapeutic innovations in radiation oncology for localized prostate cancer].
Cancer Radiother. 2017 Oct;21(6-7):454-461. doi: 10.1016/j.canrad.2017.07.037. Epub 2017 Sep 8.
10
Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Acta Oncol. 2006;45(6):717-27. doi: 10.1080/02841860600781781.
引用本文的文献
1
Comparison of Estimated Late Toxicities between IMPT and IMRT Based on Multivariable NTCP Models for High-Risk Prostate Cancers Treated with Pelvic Nodal Radiation.
Int J Part Ther. 2022 Jun 13;9(1):42-53. doi: 10.14338/IJPT-21-00042.1. eCollection 2022 Summer.
本文引用的文献
1
Treatment-Related Toxicity Using Prostate-Only Versus Prostate and Pelvic Lymph Node Intensity-Modulated Radiation Therapy: A National Population-Based Study.
J Clin Oncol. 2019 Jul 20;37(21):1828-1835. doi: 10.1200/JCO.18.02237. Epub 2019 Jun 4.
2
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline.
J Urol. 2019 Mar;201(3):528-534. doi: 10.1097/JU.0000000000000071.
3
Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study.
Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):759-769. doi: 10.1016/j.ijrobp.2016.06.2455.
4
Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.
JAMA. 2012 Apr 18;307(15):1611-20. doi: 10.1001/jama.2012.460.
5
Radiotherapy and short-term androgen deprivation for localized prostate cancer.
N Engl J Med. 2011 Jul 14;365(2):107-18. doi: 10.1056/NEJMoa1012348.
6
Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: a matched-pair comparison.
Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):23-8. doi: 10.1016/j.ijrobp.2010.05.054. Epub 2010 Sep 9.
7
Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):763-72. doi: 10.1016/j.ijrobp.2009.08.043. Epub 2010 Feb 18.
8
Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma.
Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1344-9. doi: 10.1016/j.ijrobp.2008.12.082. Epub 2009 May 21.
9
Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.
J Clin Oncol. 2008 Feb 1;26(4):585-91. doi: 10.1200/JCO.2007.13.9881. Epub 2008 Jan 2.
10
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions.
Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):646-55. doi: 10.1016/j.ijrobp.2007.04.003. Epub 2007 May 24.
Zotero 插件